MX2009006582A - Derivados de dibencil urea o-sustituida como antagonistas del receptor vaniloide del canal receptor del potencial transitorio 1. - Google Patents
Derivados de dibencil urea o-sustituida como antagonistas del receptor vaniloide del canal receptor del potencial transitorio 1.Info
- Publication number
- MX2009006582A MX2009006582A MX2009006582A MX2009006582A MX2009006582A MX 2009006582 A MX2009006582 A MX 2009006582A MX 2009006582 A MX2009006582 A MX 2009006582A MX 2009006582 A MX2009006582 A MX 2009006582A MX 2009006582 A MX2009006582 A MX 2009006582A
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxypropyl
- pain
- derivatives
- substituted
- dihydroxypropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La invención se refiere a compuestos de fórmula (I) (ver fórmula I) en donde R se selecciona de halógeno, alquilo, alcoxi, arilo y heteroarilo; R1 se selecciona de 2-hidroxietilo, 2,3-dihidroxipropilo, 3-hidroxipropilo, 2,2-dihidroxietilo, 3,3-dihidroxipropilo, 1,3-dioxolano-etilo, 1,3-dioxano-metilo, 1,3-dioxolano-metilo, 1,3-dioxano-etito, 3-fluoro-2-hidroxipropilo , 3-carboxi-2-hidroxi-propilo, 3-cloro-2-hidroxipropilo, 2-hidroxipropilo, 2-hidroxi-propen-2-ilo, morfolinoetilo, piperazinoetilo, hidroximetilo, bencilo, 4-(hidroximetil)bencilo, 4-clorobencilo, 4-fluorobencilo y 4-hidroxibencilo; R2 es terc-butilo o trifluorometilo; R3 es independientemente seleccionado de hidrógeno, carboxi, ciano, alquilo o hidroxialquilo; los compuestos de fórmula (I) se pueden usar para la preparación de composiciones farmacéuticas para la terapia de estados inflamatorios, tales como dolor neuropático crónico, síndrome de vejiga sobre-activa, dolor tumoral, hemorroides, hiperalgesia inflamatoria, dolor post-intervención, extracción dental, enfermedades de las vías respiratorias y gastrointestinales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06026533A EP1939173A1 (en) | 2006-12-21 | 2006-12-21 | O-substituted-dibenzyl urea- or thiourea- derivatives as trpv1 receptor antagonists |
| PCT/IB2007/003784 WO2008075150A1 (en) | 2006-12-21 | 2007-12-06 | O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009006582A true MX2009006582A (es) | 2009-07-02 |
Family
ID=38139789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009006582A MX2009006582A (es) | 2006-12-21 | 2007-12-06 | Derivados de dibencil urea o-sustituida como antagonistas del receptor vaniloide del canal receptor del potencial transitorio 1. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7750049B2 (es) |
| EP (2) | EP1939173A1 (es) |
| JP (1) | JP5302214B2 (es) |
| KR (1) | KR101460177B1 (es) |
| CN (1) | CN101563317B (es) |
| AT (1) | ATE479652T1 (es) |
| BR (1) | BRPI0720421A2 (es) |
| CA (1) | CA2673219C (es) |
| CY (1) | CY1110833T1 (es) |
| DE (1) | DE602007008942D1 (es) |
| DK (1) | DK2094653T3 (es) |
| EA (1) | EA015152B1 (es) |
| ES (1) | ES2347492T3 (es) |
| HR (1) | HRP20100588T1 (es) |
| IL (1) | IL199422A (es) |
| MX (1) | MX2009006582A (es) |
| NO (1) | NO20092336L (es) |
| NZ (1) | NZ577796A (es) |
| PL (1) | PL2094653T3 (es) |
| PT (1) | PT2094653E (es) |
| RS (1) | RS51555B (es) |
| SI (1) | SI2094653T1 (es) |
| UA (1) | UA95986C2 (es) |
| WO (1) | WO2008075150A1 (es) |
| ZA (1) | ZA200904278B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009037707A2 (en) | 2007-09-20 | 2009-03-26 | Ramot At Tel Aviv University Ltd. | N-phenyl anthranilic acid derivatives and uses thereof |
| CN110149795B (zh) | 2016-12-02 | 2023-10-03 | 西姆莱斯股份公司 | 化妆品混合物 |
| RU2755206C1 (ru) | 2020-05-20 | 2021-09-14 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Средство пролонгированного анальгетического действия и лекарственный препарат на его основе |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8715357D0 (en) * | 1987-06-30 | 1987-08-05 | Sandoz Inst For Medical Resear | Organic compounds |
| GB9519270D0 (en) * | 1995-09-21 | 1995-11-22 | Sandoz Pharma Uk | Organic compounds |
| DE60133743T2 (de) * | 2000-08-21 | 2009-07-02 | Pacific Corp. | Neue thiourea-derivate und pharmazeutische zusammensetzungen die diese enthalten |
| JP2003192660A (ja) * | 2001-12-26 | 2003-07-09 | Bayer Ag | 尿素誘導体 |
| US6858615B2 (en) * | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| ITMI20041231A1 (it) * | 2004-06-18 | 2004-09-18 | Pharmeste Srl | Antagonisti del recettore dei vanilloidi trpv1 |
-
2006
- 2006-12-21 EP EP06026533A patent/EP1939173A1/en not_active Withdrawn
-
2007
- 2007-06-12 UA UAA200904805A patent/UA95986C2/uk unknown
- 2007-12-06 ZA ZA200904278A patent/ZA200904278B/xx unknown
- 2007-12-06 US US12/519,753 patent/US7750049B2/en active Active
- 2007-12-06 EP EP07848984A patent/EP2094653B1/en active Active
- 2007-12-06 RS RSP-2010/0441A patent/RS51555B/en unknown
- 2007-12-06 NZ NZ577796A patent/NZ577796A/en not_active IP Right Cessation
- 2007-12-06 SI SI200730412T patent/SI2094653T1/sl unknown
- 2007-12-06 BR BRPI0720421-3A patent/BRPI0720421A2/pt not_active IP Right Cessation
- 2007-12-06 KR KR1020097012641A patent/KR101460177B1/ko active IP Right Grant
- 2007-12-06 CN CN2007800469258A patent/CN101563317B/zh active Active
- 2007-12-06 ES ES07848984T patent/ES2347492T3/es active Active
- 2007-12-06 MX MX2009006582A patent/MX2009006582A/es active IP Right Grant
- 2007-12-06 WO PCT/IB2007/003784 patent/WO2008075150A1/en active Application Filing
- 2007-12-06 DK DK07848984.6T patent/DK2094653T3/da active
- 2007-12-06 DE DE602007008942T patent/DE602007008942D1/de active Active
- 2007-12-06 EA EA200900625A patent/EA015152B1/ru not_active IP Right Cessation
- 2007-12-06 CA CA2673219A patent/CA2673219C/en active Active
- 2007-12-06 PL PL07848984T patent/PL2094653T3/pl unknown
- 2007-12-06 AT AT07848984T patent/ATE479652T1/de active
- 2007-12-06 PT PT07848984T patent/PT2094653E/pt unknown
- 2007-12-06 JP JP2009542247A patent/JP5302214B2/ja active Active
-
2009
- 2009-06-18 NO NO20092336A patent/NO20092336L/no not_active Application Discontinuation
- 2009-06-18 IL IL199422A patent/IL199422A/en active IP Right Grant
-
2010
- 2010-10-18 CY CY20101100925T patent/CY1110833T1/el unknown
- 2010-11-02 HR HR20100588T patent/HRP20100588T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2094653B1 (en) | 2010-09-01 |
| EA015152B1 (ru) | 2011-06-30 |
| PL2094653T3 (pl) | 2011-02-28 |
| JP5302214B2 (ja) | 2013-10-02 |
| IL199422A (en) | 2015-01-29 |
| US7750049B2 (en) | 2010-07-06 |
| ZA200904278B (en) | 2010-08-25 |
| ATE479652T1 (de) | 2010-09-15 |
| EP2094653A1 (en) | 2009-09-02 |
| EP1939173A1 (en) | 2008-07-02 |
| DE602007008942D1 (de) | 2010-10-14 |
| ES2347492T3 (es) | 2010-10-29 |
| NO20092336L (no) | 2009-06-18 |
| CN101563317A (zh) | 2009-10-21 |
| CA2673219C (en) | 2015-04-14 |
| UA95986C2 (uk) | 2011-09-26 |
| US20100105740A1 (en) | 2010-04-29 |
| RS51555B (en) | 2011-06-30 |
| CA2673219A1 (en) | 2008-06-26 |
| JP2010513455A (ja) | 2010-04-30 |
| CY1110833T1 (el) | 2015-06-10 |
| SI2094653T1 (sl) | 2011-01-31 |
| PT2094653E (pt) | 2010-09-23 |
| BRPI0720421A2 (pt) | 2013-12-31 |
| KR20090090347A (ko) | 2009-08-25 |
| EA200900625A1 (ru) | 2009-12-30 |
| NZ577796A (en) | 2011-10-28 |
| CN101563317B (zh) | 2012-12-12 |
| HRP20100588T1 (hr) | 2010-12-31 |
| WO2008075150A1 (en) | 2008-06-26 |
| KR101460177B1 (ko) | 2014-11-10 |
| DK2094653T3 (da) | 2010-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091620L (no) | Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser | |
| NO20083690L (no) | Hydantoin baserte kinase-inhibitorer | |
| TW200604183A (en) | Triazole compounds and their use as metabotropic glutamate receptor antagonists | |
| MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
| WO2006123113A3 (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
| EA201071232A1 (ru) | Триазины как ингибиторы киназы pi3 и mtor | |
| MX2008005398A (es) | Derivados de 4-(3-amino-pirazol)-pirimidina para uso como inhibidores de tirosina cinasa en el tratamiento de cancer. | |
| WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
| NO20090979L (no) | (3-amino-1,2,3,4-tetrahydro-9H-karbazol-9-yl)-eddiksyrederivater | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| EA200900213A1 (ru) | Ингибиторы обратной транскриптазы вич (варианты), фармацевтическая композиция на их основе, способ ингибирования репликации ретровируса с их помощью и названные ингибиторы для изготовления лекарственного средства для ингибирования обратной транскриптазы вич и для лечения или профилактики инфекционного вич | |
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| EA201000805A1 (ru) | Бис-(сульфониламино)производные в терапии 066 | |
| EA201100391A1 (ru) | Соединения, ингибирующие активность семикарбазид-чувствительной аминооксидазы | |
| EA201290183A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| IL198226A0 (en) | 2-[l-phenyl-5-hydroxy-4alpha-methyl | |
| WO2008030744A3 (en) | Inhibitors of c-met and uses thereof | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| NZ613235A (en) | Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors | |
| EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
| GEP20125459B (en) | Compounds for inhibiting mitotic progression | |
| GEP20146131B (en) | Carbazole compounds and therapeutic uses thereof | |
| UA92670C2 (ru) | Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе | |
| EA201071269A1 (ru) | 3,4-замещенные пиперидиновые производные в качестве ингибиторов ренина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |